Active, not recruiting trials in France: Trial Insights

Filters: Status: Active, not recruiting Country / region: France Clear all

2,224 trials match Source: ClinicalTrials.gov registrations

Trials started per year
Category	Trials
2000	1
2003	1
2005	1
2007	2
2008	6
2009	6
2010	3
2011	9
2012	10
2013	25
2014	29
2015	35
2016	59
2017	92
2018	123
2019	178
2020	201
2021	284
2022	304
2023	314
2024	323
2025	188
2026	27

Trials by status
Category	Trials
Active, not recruiting	2,224

Top lead sponsors
Category	Trials
AstraZeneca	95
Novartis Pharmaceuticals	92
Hoffmann-La Roche	72
Assistance Publique - Hôpitaux de Paris	70
Janssen Research & Development, LLC	58
AbbVie	51
Merck Sharp & Dohme LLC	51
Eli Lilly and Company	40
Centre Hospitalier Universitaire de Nice	39
UNICANCER	37

Top conditions
Category	Trials
Carcinoma, Non-Small-Cell Lung	141
Breast Neoplasms	109
Neoplasms	98
Neoplasm Metastasis	66
Multiple Myeloma	56
Prostatic Neoplasms	53
Colorectal Neoplasms	44
Melanoma	42
Ovarian Neoplasms	40
Recurrence	38

Trials

Showing 51 to 75 of 2,224. Each trial links to its page on Pharma Observatory.

Effect of Combining a Posterosuperior Humeral Notch Filling With a Coracoid Bone Block on the Rate of Return to Sport NCT07257081Not applicableActive, not recruitingClinique Saint Jean, FranceStarted 2025
Early Feasibility Study (EFS) of Abbott's Balloon-expandable (BE) TAVI System for the Treatment of Severe, Symptomatic Aortic Stenosis NCT07116551Not applicableActive, not recruitingAbbott Medical DevicesStarted 2025
A Study Comparing Navlimetostat (BMS-986504) in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine in Participants With Untreated Metastatic Pancreatic Ductal Adenocarcinoma With Homozygous MTAP Deletion (MountainTAP-30) NCT07076121Phase 2/3Active, not recruitingBristol-Myers SquibbStarted 2025
A Safety and Efficacy Study of GTX-102 in Subjects With Deletion- or Nondeletion-type Angelman Syndrome (AS) NCT07157254Phase 2Active, not recruitingUltragenyx Pharmaceutical IncStarted 2025
Efficacy of Virtual Reality Reminiscence Therapy in Nursing Home Residents With Alzheimer's Disease or Related Diseases NCT06960915Not applicableActive, not recruitingCentre Hospitalier Universitaire, AmiensStarted 2025
A Safety and Performance Study of the Use of EmboBio for the Intra-arterial Treatment of Abdominopelvic Bleeding NCT07199348Not applicableActive, not recruitingEmbobio MedicalStarted 2025
IMMUNORARE5: A National Platform of 5 Academic Phase II Trials Coordinated by Lyon University Hospital to Assess the Safety and the Efficacy of the IMMUNOtherapy With Domvanalimab + Zimberelimab Combination in Patients With Advanced RARE Cancers NCT06790706Phase 2Active, not recruitingHospices Civils de LyonStarted 2025
A Study of NT 201 in Adults With Moderate to Severe Platysma Prominence in Europe (PLATINUM EU) NCT07210463Phase 3Active, not recruitingMerz Aesthetics GmbHStarted 2025
Stability of Distal Tibiofibular Syndesmosis With or Without Fixation of Posterior Fragments in Bimalleolar Fractures NCT07755462Not applicableActive, not recruitingGroupe Hospitalier Diaconesses Croix Saint-SimonStarted 2025
Research on the Evolution, Geometry, and Alterations of the Periorbital Region Based on Age and Deformations NCT07080320Not applicableActive, not recruitingCentre Hospitalier Universitaire, AmiensStarted 2025
A Study to Evaluate Two Dosing Regimens of Subcutaneous Nivolumab in Combination With Intravenous Ipilimumab and Chemotherapy in Participants With Previously Untreated Metastatic or Recurrent Non-Small Cell Lung Cancer (NSCLC) NCT06946797Phase 2Active, not recruitingBristol-Myers SquibbStarted 2025
A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease NCT07169578Phase 3Active, not recruitingHoffmann-La RocheStarted 2025
Evaluation of MIG-SPRAY Treatment on Migraine NCT07100496Phase 4Active, not recruitingUniversity Hospital, Clermont-FerrandStarted 2025
A Study to Test Whether Nerandomilast Helps People With Lung Fibrosis Related to Rheumatic Diseases NCT06806592Phase 3Active, not recruitingBoehringer IngelheimStarted 2025
Clinical Performance and Safety of STYLAGE® HydroMax NCT07153237Not applicableActive, not recruitingLaboratoires VivacyStarted 2025
Eating Disturbances in Patients With Type 1 Diabetes Initiating Insulin Therapy NCT07151924ObservationalActive, not recruitingUniversity Hospital, ToulouseStarted 2025
Longitudinal Monitoring of Head Impacts in Elite Junior Ice Hockey NCT07341880ObservationalActive, not recruitingUniversity Hospital, CaenStarted 2025
Predictive Validity of the Chelsea Critical Care Physical Assessment Tool (CPAx) for Regaining Autonomy Three Months After ICU Discharge NCT07167121ObservationalActive, not recruitingCentre Hospitalier Intercommunal Elbeuf-Louviers-Val de ReuilStarted 2025
Comparison of Two Methods of Immunoprophylaxis Against RSV in Term Newborns NCT07251972ObservationalActive, not recruitingJean-Michel HASCOETStarted 2025
Defining Dosimetric Reference Levels in Computed Tomography Spectral Scanning NCT07305103ObservationalActive, not recruitingCentre Hospitalier Universitaire de NīmesStarted 2025
Analgesic Amputation for Algodystrophy: Feedback From a Case Series NCT07364266ObservationalActive, not recruitingUniversity Hospital, BrestStarted 2025
Acute Effect of Polyphenols Supplementation on Endothelial Function and Exercise Related Markers, in Physically Active Healthy Volunteers. NCT07518758Not applicableActive, not recruitingNexiraStarted 2025
Retrospective Evaluation of the Implementation of a Digital Solution Supporting the Delivery of Pulmonary Rehabilitation Programs in Private Physiotherapy Practice NCT07687836ObservationalActive, not recruitingADIR AssociationStarted 2025
Study of Re-Treatment With ALXN2220 in Patients With ATTR-CM NCT07213583Phase 2Active, not recruitingNeurimmune AGStarted 2025
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine NCT07018700Phase 3Active, not recruitingMerz Therapeutics GmbHStarted 2025

2,124 more trials match. See them on Pharma Observatory

Beta-lactam Intermittent Versus Continuous Infusion and Combination Antibiotic Therapy in Sepsis NCT05681442Completion date change2027-06-04 to 2027-03-04October 18, 2026
Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease NCT06332534Completion date change2034-12-31 to 2031-01-31October 18, 2026
A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis NCT06461897Completion date change2030-07-31 to 2029-11-30October 18, 2026
A Study to Assess the Efficacy and Safety of Efgartigimod PH20 SC in Adults With Systemic Sclerosis NCT06655155Completion date change2027-09-30 to 2027-10-31October 18, 2026
Cardiac Resynchronization Therapy in Previously Untreatable and High Risk Upgrade Patients NCT02922036Completion date change2026-06-30 to 2027-11-30October 18, 2026
A Study of Ripretinib vs Sunitinib in Advanced GIST Patients After Treatment With Imatinib NCT03673501Completion date change2026-12-31 to 2027-12-31October 18, 2026
A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease NCT05271409Enrollment change132 to 139October 18, 2026
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis NCT06329401Enrollment change375 to 398October 18, 2026
Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease NCT06332534Enrollment change110 to 111October 18, 2026
A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis NCT06461897Enrollment change675 to 699October 18, 2026

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.

Visit Pharma Observatory